Existence of Leukemic Clones Resistant to Both Imatinib Mesylate and Rituximab before Drug Therapies...
Existence of Leukemic Clones Resistant to Both Imatinib Mesylate and Rituximab before Drug Therapies in a Patient with Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia
About this item
Full title
Author / Creator
Publisher
Tokyo: Springer
Journal title
Language
English
Formats
Publication information
Publisher
Tokyo: Springer
Subjects
More information
Scope and Contents
Contents
Imatinib mesylate and rituximab are molecularly targeted drugs against the BCR-ABL fusion protein and the CD20 antigen, respectively. Although these drugs have excellent anticancer effects, a major concern is drug resistance. We have investigated the case of a patient with Philadelphia chromosome-positive and CD20+ acute lymphocytic leukemia who ac...
Alternative Titles
Full title
Existence of Leukemic Clones Resistant to Both Imatinib Mesylate and Rituximab before Drug Therapies in a Patient with Philadelphia Chromosome-Positive Acute Lymphocytic Leukemia
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_66756174
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_66756174
Other Identifiers
ISSN
0925-5710
E-ISSN
1865-3774
DOI
10.1532/IJH97.04033
